PB Ratio of Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd
NSE: BIOFILCHEM
PB Ratio
Key Highlights
- The latest PB Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 2.3.
- The PB ratio of the Biofil Chemicals & Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 6.6 on March 2021 to 2 on March 2026 . This represents a CAGR of -18.04% over 6 years .
Historical P/B Ratio of Biofil Chemicals & Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Biofil Chemicals & Pharmaceuticals Ltd
Company Fundamentals for Biofil Chemicals & Pharmaceuticals Ltd
Market Cap
49 Cr
EPS
0.3
P/E Ratio (TTM)
98.6
P/B Ratio (TTM)
2.2
Day’s High
32.98
Day’s Low
29.67
DTE
0.1
ROE
12.9
52 Week High
46.82
52 Week Low
25.6
ROCE
14.1
Market Price of Biofil Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 30.38 |
| 05 Oct 2026 | 29.57 |
| 01 Oct 2026 | 29.64 |
| 30 Sep 2026 | 30.31 |
| 29 Sep 2026 | 31.82 |
| 28 Sep 2026 | 31.51 |
| 25 Sep 2026 | 32.75 |
| 24 Sep 2026 | 32.08 |
| 23 Sep 2026 | 32.26 |
| 22 Sep 2026 | 32.3 |
SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd
BlinkX Score for Biofil Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of Biofil Chemicals & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Biofil Chemicals & Pharmaceuticals Ltd | 2.23 | 48.11 |
| Sun Pharmaceutical Industries Ltd | 93.2 | 432120 |
| Divis Laboratories Ltd | 629.5 | 253390 |
| Torrent Pharmaceuticals Ltd | 222.8 | 181740 |
| Zydus Lifesciences Ltd | 237.3 | 115710 |
PB Ratio of Biofil Chemicals & Pharmaceuticals Ltd Explained
₹48.11
Market cap
₹13
Book Value per Share
2.2X
PB Ratio
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Biofil Chemicals & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Biofil Chemicals & Pharmaceuticals Ltd News Hub
Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter
Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the quarter end
Read more
14 Aug 24
Biofil Chemicals & Pharmaceuticals to table results
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
12 Aug 24
Biofil Chemicals & Pharmaceuticals AGM scheduled
Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa
Read more
10 Sept 24
Biofil Chemicals & Pharmaceuticals to conduct board meeting
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1
Read more
08 Nov 24
